Evidence map›Paper›PMID 30110158›Full record

ArticleBiomacromolecules2018

Tunability of Biodegradable Poly(amine- co-ester) Polymers for Customized Nucleic Acid Delivery and Other Biomedical Applications.

Amy C Kauffman, Alexandra S Piotrowski-Daspit, Kay H Nakazawa, Yuhang Jiang, Amit Datye, W Mark Saltzman

Abstract read
In one paragraph

Article in Biomacromolecules, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Engineered cargo-free nanoparticle decoys for phagocytic modulation of macrophages.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Dynamic carriers for therapeutic RNA delivery.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Article
  16. Rational nanoparticle design: Optimization using insights from experiments and mathematical models.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Review
  17. Molecular therapy. Nucleic acids · 2023
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amy C Kauffman
Alexandra S Piotrowski-Daspit
Kay H Nakazawa
Yuhang Jiang
Amit Datye
Yale University · US

Funding

Research Training in AnesthesiaT32GM086287 · NIGMS · YALE UNIVERSITY · PI ROBERT SCHONBERGER · 2009 to 2026
$3.7M
Poly(amine-co-ester)s for targeted delivery of gene editing agents to treat cystic fibrosis in animal models: SCGE Disease Models Studies SupplementUH3HL147352 · NHLBI · YALE UNIVERSITY · PI GLAZER, PETER M, SALTZMAN, W. MARK · 2021 to 2022
$2.4M
Targeted correction of the human CFTR geneR01HL125892 · NHLBI · YALE UNIVERSITY · PI EGAN, MARIE E, GLAZER, PETER M · 2015 to 2018
$2.2M
Yale Interdisciplinary Bioengineering Training Grant for Diabetes ResearchT32DK101019 · NIDDK · YALE UNIVERSITY · PI SALTZMAN, W. MARK · 2013 to 2017
$1.5M
Developing Poly(amine-co-ester) Polymeric Delivery Vehicles and 3D Culture Screening Platforms for the Treatment of Hereditary Beta-thalassemia with Peptide Nucleic Acid Genome Editing TechnologyF32HL142144 · NHLBI · YALE UNIVERSITY · PI PIOTROWSKI-DASPIT, ALEXANDRA SARAH ANNUKKA · 2018 to 2019
$123k
NHLBI NIH HHS F32 HL142144NHLBI NIH HHS R01 HL125892NHLBI NIH HHS UH3 HL147352NIDDK NIH HHS T32 DK101019NIGMS NIH HHS T32 GM086287
6 · The paper itself

Abstract

Gene therapy promises to treat diseases that arise from genetic abnormalities by correcting the underlying cause of the disease rather than treating the associated symptoms. Successful transfer of nucleic acids into cells requires efficient delivery vehicles that protect the cargo and can penetrate the appropriate cellular barriers before releasing their contents. Many viral vectors and synthetic polycationic vectors for nucleic acid delivery do not translate well from in vitro to in vivo applications due to their instability and toxicity. We synthesized and characterized a library of biocompatible low charge density polymers from a family of poly(amine- co-ester) (PACE) terpolymers produced via enzyme catalyzed polymerization. PACE polymers are highly customizable; we found that the terpolymer composition can be optimized to produce efficient transfection of various nucleic acids-including DNA plasmids, mRNA, and siRNA-in specific cell types with low toxicity. Our findings suggest that the unique tunability of PACEs offers new tools for gene therapy and other biomedical applications.

Indexed as

Gene Transfer Techniques3,4-Methylenedioxyamphetamine3T3 CellsAnimalsDecanoic AcidsDicarboxylic AcidsEstersHEK293 CellsHumansMacrolidesMiceNanoparticlesPolyaminesPolymerization3,4-Methylenedioxyamphetamine3,4-methylenedioxyethamphetamineDecanoic AcidsDicarboxylic AcidsEstersMacrolidesomega-pentadecalactonePolyaminessebacic acid

Identifiers

PMID30110158
PMCPMC6510397
OpenAlexW2885485598

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.